Literature DB >> 33681390

Hypoxia-Induced Autophagy Enhances Cisplatin Resistance in Human Bladder Cancer Cells by Targeting Hypoxia-Inducible Factor-1α.

Xiawa Mao1, Jiaquao Xiao1, Huifeng Wu1, Kefeng Ding2.   

Abstract

PURPOSE: To investigate the effect of hypoxia on chemoresistance and the underlying mechanism in bladder cancer cells.
METHODS: BIU-87 bladder cancer cell line was treated with cisplatin under hypoxic and normoxic conditions and tested using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, flow cytometry, and Western blotting. All the data were expressed as mean ± standard error from three independent experiments and analyzed by multiple t-tests.
RESULTS: Apoptosis of bladder cancer cells caused by cisplatin was attenuated in hypoxic conditions. Hypoxia enhanced autophagy caused by cisplatin. The autophagy inhibitor and HIF-1α inhibitor can reverse the chemoresistance in hypoxic condition. Apoptosis and autophagy of bladder cancer cells were downregulated by HIF-1α inhibitor YC-1. Hypoxia-induced autophagy enhanced chemoresistance to cisplatin via the HIF-1 signaling pathway.
CONCLUSION: Resistance to cisplatin in BIU-87 bladder cancer cells under hypoxic conditions can be explained by activation of autophagy, which is regulated by HIF-1α-associated signaling pathways. The hypoxia-autophagy pathway may be a target for improving the efficacy of cisplatin chemotherapy in bladder cancer.
Copyright © 2021 Xiawa Mao et al.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33681390      PMCID: PMC7904373          DOI: 10.1155/2021/8887437

Source DB:  PubMed          Journal:  J Immunol Res        ISSN: 2314-7156            Impact factor:   4.818


  37 in total

1.  Reactive oxygen species-linked regulation of the multidrug resistance transporter P-glycoprotein in Nox-1 overexpressing prostate tumor spheroids.

Authors:  Maria Wartenberg; Edda Hoffmann; Heinrich Schwindt; Frank Grünheck; John Petros; J Rebecca S Arnold; Jürgen Hescheler; Heinrich Sauer
Journal:  FEBS Lett       Date:  2005-08-15       Impact factor: 4.124

Review 2.  Tumor hypoxia and cancer progression.

Authors:  Jie Zhou; Tobias Schmid; Steffen Schnitzer; Bernhard Brüne
Journal:  Cancer Lett       Date:  2005-07-05       Impact factor: 8.679

3.  Hypoxia-induced autophagy: cell death or cell survival?

Authors:  Nathalie M Mazure; Jacques Pouysségur
Journal:  Curr Opin Cell Biol       Date:  2009-12-21       Impact factor: 8.382

4.  Chronic hypoxia promotes hypoxia-inducible factor-1alpha-dependent resistance to etoposide and vincristine in neuroblastoma cells.

Authors:  Deema Hussein; Edward J Estlin; Caroline Dive; Guy W J Makin
Journal:  Mol Cancer Ther       Date:  2006-09       Impact factor: 6.261

Review 5.  Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012.

Authors:  L Galluzzi; I Vitale; J M Abrams; E S Alnemri; E H Baehrecke; M V Blagosklonny; T M Dawson; V L Dawson; W S El-Deiry; S Fulda; E Gottlieb; D R Green; M O Hengartner; O Kepp; R A Knight; S Kumar; S A Lipton; X Lu; F Madeo; W Malorni; P Mehlen; G Nuñez; M E Peter; M Piacentini; D C Rubinsztein; Y Shi; H-U Simon; P Vandenabeele; E White; J Yuan; B Zhivotovsky; G Melino; G Kroemer
Journal:  Cell Death Differ       Date:  2011-07-15       Impact factor: 15.828

Review 6.  [Hypoxia-inducible factor 1: regulation, involvement in carcinogenesis and target for anticancer therapy].

Authors:  Eric Clottes
Journal:  Bull Cancer       Date:  2005-02       Impact factor: 1.276

Review 7.  Tumour hypoxia affects the responsiveness of cancer cells to chemotherapy and promotes cancer progression.

Authors:  Jean-Philippe Cosse; Carine Michiels
Journal:  Anticancer Agents Med Chem       Date:  2008-10       Impact factor: 2.505

Review 8.  Solid tumor physiology and hypoxia-induced chemo/radio-resistance: novel strategy for cancer therapy: nitric oxide donor as a therapeutic enhancer.

Authors:  Hiroyasu Yasuda
Journal:  Nitric Oxide       Date:  2008-05-06       Impact factor: 4.427

9.  Autophagy‑mediated adaptation of hepatocellular carcinoma cells to hypoxia‑mimicking conditions constitutes an attractive therapeutic target.

Authors:  Satoshi Owada; Hitoshi Endo; Yukari Shida; Chisa Okada; Kanako Ito; Takahiro Nezu; Masayuki Tatemichi
Journal:  Oncol Rep       Date:  2018-02-23       Impact factor: 3.906

10.  Hypoxia-induced autophagy promotes gemcitabine resistance in human bladder cancer cells through hypoxia-inducible factor 1α activation.

Authors:  Xiaoyu Yang; Hubin Yin; Yunzhi Zhang; Xinyuan Li; Hang Tong; Yizhou Zeng; Quan Wang; Weiyang He
Journal:  Int J Oncol       Date:  2018-04-24       Impact factor: 5.650

View more
  8 in total

1.  Dysregulation of iron homeostasis and methamphetamine reward behaviors in Clk1-deficient mice.

Authors:  Peng-Ju Yan; Zhao-Xiang Ren; Zhi-Feng Shi; Chun-Lei Wan; Chao-Jun Han; Liu-Shuai Zhu; Ning-Ning Li; John L Waddington; Xue-Chu Zhen
Journal:  Acta Pharmacol Sin       Date:  2021-11-22       Impact factor: 7.169

2.  A reduced level of the long non-coding RNA SNHG8 activates the NF-kappaB pathway by releasing functional HIF-1alpha in a hypoxic inflammatory microenvironment.

Authors:  Chenxin Wang; Qiaolin Yang; Yineng Han; Hao Liu; Yue Wang; Yiping Huang; Yunfei Zheng; Weiran Li
Journal:  Stem Cell Res Ther       Date:  2022-06-03       Impact factor: 8.079

Review 3.  Recent Advances of Autophagy in Non-Small Cell Lung Cancer: From Basic Mechanisms to Clinical Application.

Authors:  Weina Guo; Keye Du; Shanshan Luo; Desheng Hu
Journal:  Front Oncol       Date:  2022-05-04       Impact factor: 5.738

4.  Identifying a hypoxia related score to predict the prognosis of bladder cancer: a study with The Cancer Genome Atlas (TCGA) database.

Authors:  Zhenan Zhang; Qinhan Li; Aolin Li; Feng Wang; Zhicun Li; Yisen Meng; Qian Zhang
Journal:  Transl Androl Urol       Date:  2021-12

5.  Eukaryotic initiation factor 5A2 mediates hypoxia-induced autophagy and cisplatin resistance.

Authors:  Guodong Xu; Hang Chen; Shibo Wu; Jiabin Chen; Shufen Zhang; Guofeng Shao; Lebo Sun; Yinyu Mu; Kaitai Liu; Qiaoling Pan; Ni Li; Xiaoxia An; Shuang Lin; Wei Chen
Journal:  Cell Death Dis       Date:  2022-08-05       Impact factor: 9.685

6.  Construction and verification of a novel hypoxia-related lncRNA signature related with survival outcomes and immune microenvironment of bladder urothelial carcinoma by weighted gene co-expression network analysis.

Authors:  Dawei Cai; Zhongbao Zhou; Guangzhu Wei; Peishan Wu; Guangqi Kong
Journal:  Front Genet       Date:  2022-08-31       Impact factor: 4.772

Review 7.  Cisplatin for cancer therapy and overcoming chemoresistance.

Authors:  Ranmali Ranasinghe; Michael L Mathai; Anthony Zulli
Journal:  Heliyon       Date:  2022-09-14

8.  Autophagy-associated circular RNA hsa_circ_0007813 modulates human bladder cancer progression via hsa-miR-361-3p/IGF2R regulation.

Authors:  Zheyu Zhang; Zezhong Mou; Chenyang Xu; Siqi Wu; Xiyu Dai; Xinan Chen; Yuxi Ou; Yiling Chen; Chen Yang; Haowen Jiang
Journal:  Cell Death Dis       Date:  2021-08-07       Impact factor: 8.469

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.